Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

HIV Infection

Free Subscription Articles published in HIV Med Retrieve available abstracts of 95 articles: HTML format Text format

Single Articles

February 2012
1. MONROE A , Dobs A, Xu X, Palella F, et al
   Low free testosterone in HIV-infected men is not associated with subclinical cardiovascular disease.
   HIV Med. 2012 Feb 2. doi: 10.1111/j.1468-1293.2011.00988.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. MARUSZAK H , Jeganathan S, Smith D, Robertson P, et al
   Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.
   HIV Med. 2012 Feb 2. doi: 10.1111/j.1468-1293.2011.00987.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. 
   Guidance on vaccination of HIV-infected children in Europe.
   HIV Med. 2012 Feb 2. doi: 10.1111/j.1468-1293.2011.00982.
   PubMed     Text format     Related articles   
   
   
   
   
4. HERMANS S , van Leth F, Manabe Y, Hoepelman A, et al
   Earlier initiation of antiretroviral therapy, increased tuberculosis case finding and reduced mortality in a setting of improved HIV care: a retrospective cohort study.
   HIV Med. 2012 Feb 2. doi: 10.1111/j.1468-1293.2011.00980.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2012
5. BEDIMO R , Kyriakides T, Brown S, Weidler J, et al
   Predictive value of HIV-1 replication capacity and phenotypic susceptibility scores in antiretroviral treatment-experienced patients.
   HIV Med. 2012 Jan 26. doi: 10.1111/j.1468-1293.2011.00981.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. ROUTY J , Tremblay C, Angel J, Trottier B, et al
   Valproic acid in association with highly active antiretroviral therapy for reducing systemic HIV-1 reservoirs: results from a multicentre randomized clinical study.
   HIV Med. 2012 Jan 26. doi: 10.1111/j.1468-1293.2011.00975.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. MITCHELL D , Israr M, Alam S, Kishel J, et al
   Effect of the HIV nucleoside reverse transcriptase inhibitor zidovudine on the growth and differentiation of primary gingival epithelium.
   HIV Med. 2012 Jan 26. doi: 10.1111/j.1468-1293.2011.00973.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. PIERCE A , Armishaw J, Price B, Wright E, et al
   Nonoccupational post-exposure prophylaxis source tracing: is it really feasible in Australia?
   HIV Med. 2012 Jan 25. doi: 10.1111/j.1468-1293.2011.00986.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. RICE B , Gilbart V, Lawrence J, Smith R, et al
   Safe travels? HIV transmission among Britons travelling abroad.
   HIV Med. 2012 Jan 25. doi: 10.1111/j.1468-1293.2011.00983.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. SHADYAB A , Crum-Cianflone N
    Methicillin-resistant Staphylococcus aureus (MRSA) infections among HIV-infected persons in the era of highly active antiretroviral therapy: a review of the literature.
    HIV Med. 2012 Jan 25. doi: 10.1111/j.1468-1293.2011.00978.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. KANG M , Cu-Uvin S
    Association of HIV viral load and CD4 cell count with human papillomavirus detection and clearance in HIV-infected women initiating highly active antiretroviral therapy.
    HIV Med. 2012 Jan 19. doi: 10.1111/j.1468-1293.2011.00979.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. CEPERUELO-MALLAFRE V , Escote X, Vilades C, Peraire J, et al
    Zinc alpha-2 glycoprotein is implicated in dyslipidaemia in HIV-1-infected patients treated with antiretroviral drugs.
    HIV Med. 2012 Jan 19. doi: 10.1111/j.1468-1293.2011.00976.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. JARDI R , Crespo M, Homs M, Van den Eyden E, et al
    HIV, HEV and cirrhosis: evidence of a possible link from eastern Spain.
    HIV Med. 2012 Jan 18. doi: 10.1111/j.1468-1293.2011.00985.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. HUBER M , Ledergerber B, Sauter R, Young J, et al
    Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians.
    HIV Med. 2012 Jan 18. doi: 10.1111/j.1468-1293.2011.00984.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. RAO N , Patel V, Grigoriu A, Kaushik P, et al
    Antiretroviral therapy prescribing in hospitalized HIV clinic patients.
    HIV Med. 2012 Jan 18. doi: 10.1111/j.1468-1293.2011.00977.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. CHOW E , Wilson D, Zhang L
    The rate of HIV testing is increasing among men who have sex with men in China.
    HIV Med. 2012 Jan 18. doi: 10.1111/j.1468-1293.2011.00974.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. ASBOE D , Aitken C, Boffito M, Booth C, et al
    British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011.
    HIV Med. 2012;13:1-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
18. DOLLING D , Phillips A, Delpech V, Pillay D, et al
    Evaluating the extent of potential resistance to pre-exposure prophylaxis within the UK HIV-1-infectious population of men who have sex with men.
    HIV Med. 2011 Dec 12. doi: 10.1111/j.1468-1293.2011.00968.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. WINSTON A , Puls R, Kerr S, Duncombe C, et al
    Dynamics of cognitive change in HIV-infected individuals commencing three different initial antiretroviral regimens: a randomized, controlled study.
    HIV Med. 2011 Dec 12. doi: 10.1111/j.1468-1293.2011.00962.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. KENNY J , Williams B, Prime K, Tookey P, et al
    Pregnancy outcomes in adolescents in the UK and Ireland growing up with HIV.
    HIV Med. 2011 Dec 4. doi: 10.1111/j.1468-1293.2011.00967.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. CARVALHO A , Valadas E, Franca L, Carvalho C, et al
    Population mobility and the changing epidemics of HIV-2 in Portugal.
    HIV Med. 2011 Dec 4. doi: 10.1111/j.1468-1293.2011.00963.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. MILLER T , Borkowsky W, Dimeglio L, Dooley L, et al
    Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected children.
    HIV Med. 2011 Dec 4. doi: 10.1111/j.1468-1293.2011.00970.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. ARASTEH K , Ward D, Plettenberg A, Livrozet J, et al
    Twenty-four-week efficacy and safety of switching virologically suppressed HIV-1-infected patients from nevirapine immediate release 200 mg twice daily to nevirapine extended release 400 mg once daily (TRANxITION).
    HIV Med. 2011 Dec 4. doi: 10.1111/j.1468-1293.2011.00969.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
24. STEK A , Best B, Luo W, Capparelli E, et al
    Effect of pregnancy on emtricitabine pharmacokinetics.
    HIV Med. 2011 Nov 30. doi: 10.1111/j.1468-1293.2011.00965.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. ASIIMWE F , Moore D, Were W, Nakityo R, et al
    Clinical outcomes of HIV-infected patients with Kaposi's sarcoma receiving nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy in Uganda.
    HIV Med. 2011 Nov 24. doi: 10.1111/j.1468-1293.2011.00955.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. PICHENOT M , Deuffic-Burban S, Cuzin L, Yazdanpanah Y, et al
    Efficacy of new antiretroviral drugs in treatment-experienced HIV-infected patients: a systematic review and meta-analysis of recent randomized controlled trials.
    HIV Med. 2011 Nov 22. doi: 10.1111/j.1468-1293.2011.00953.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. NANZIGU S , Eriksen J, Makumbi F, Lanke S, et al
    Pharmacokinetics of the nonnucleoside reverse transcriptase inhibitor efavirenz among HIV-infected Ugandans.
    HIV Med. 2011 Nov 22. doi: 10.1111/j.1468-1293.2011.00952.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. AHO J , Nguyen VK, Diakite S, Sow A, et al
    High acceptability of HIV voluntary counselling and testing among female sex workers: impact of individual and social factors.
    HIV Med. 2011 Nov 22. doi: 10.1111/j.1468-1293.2011.00951.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. MTAMBO A , Chan K, Shen A, Lima V, et al
    Treatment limitations imposed by antiretroviral drug resistance mutations: implication for choices of first line regimens in resource-limited settings.
    HIV Med. 2011 Nov 22. doi: 10.1111/j.1468-1293.2011.00950.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. THIERFELDER C , Weber R, Elzi L, Furrer H, et al
    Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study(*).
    HIV Med. 2011 Nov 22. doi: 10.1111/j.1468-1293.2011.00949.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. KOBER C , Johnson M, Fisher M, Hill T, et al
    Non-uptake of highly active antiretroviral therapy among patients with a CD4 count < 350 cells/muL in the UK.
    HIV Med. 2011 Nov 22. doi: 10.1111/j.1468-1293.2011.00956.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. KRANZER K , Govindasamy D, van Schaik N, Thebus E, et al
    Incentivized recruitment of a population sample to a mobile HIV testing service increases the yield of newly diagnosed cases, including those in need of antiretroviral therapy.
    HIV Med. 2011 Nov 21. doi: 10.1111/j.1468-1293.2011.00947.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. LOUTFY M , Raboud J, Wong J, Yudin M, et al
    High prevalence of unintended pregnancies in HIV-positive women of reproductive age in Ontario, Canada: a retrospective study.
    HIV Med. 2011 Nov 21. doi: 10.1111/j.1468-1293.2011.00946.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. ROSS A , Leong T, Avery A, Castillo-Duran M, et al
    Effects of in utero antiretroviral exposure on mitochondrial DNA levels, mitochondrial function and oxidative stress.
    HIV Med. 2011 Nov 21. doi: 10.1111/j.1468-1293.2011.00945.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. ANDREWS S , Handyside R, Carpenter L, Price A, et al
    Testing children of mothers with HIV infection: experience in three south-west London HIV clinics.
    HIV Med. 2011 Nov 16. doi: 10.1111/j.1468-1293.2011.00948.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. CALMY A , Bel M, Nguyen A, Combescure C, et al
    Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients.
    HIV Med. 2011 Nov 7. doi: 10.1111/j.1468-1293.2011.00961.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. ZOUFALY A , An der Heiden M, Marcus U, Hoffmann C, et al
    Late presentation for HIV diagnosis and care in Germany.
    HIV Med. 2011 Nov 7. doi: 10.1111/j.1468-1293.2011.00958.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. TURNER D , Amit S, Chalom S, Penn O, et al
    Emergence of an HIV-1 cluster harbouring the major protease L90M mutation among treatment-naive patients in Tel Aviv, Israel.
    HIV Med. 2011 Nov 3. doi: 10.1111/j.1468-1293.2011.00960.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. DICKSON N , McAllister S, Sharples K, Paul C, et al
    Late presentation of HIV infection among adults in New Zealand: 2005-2010.
    HIV Med. 2011 Nov 3. doi: 10.1111/j.1468-1293.2011.00959.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
40. KUNISAKI K , Quick H, Baker J
    HIV antiretroviral therapy reduces circulating surfactant protein-D levels.
    HIV Med. 2011;12:580-1.
    PubMed     Text format     Related articles   
    
    
    
    
41. POZNIAK A , Coyne K, Miller R, Lipman M, et al
    British HIV Association guidelines for the treatment of TB/HIV coinfection 2011.
    HIV Med. 2011;12:517-24.
    PubMed     Text format     Related articles   
    
    
    
    September 2011
42. HOSEIN S , Wilson D
    Decision-making by people living with HIV requires communication from clinicians about the risks of transmission despite undetectable plasma viral load.
    HIV Med. 2011;12:516.
    PubMed     Text format     Related articles   
    
    
    
    
43. WESTON R , Khoo S
    13 A-Z of drugs used in the treatment of opportunist infections in HIV (Appendix 1).
    HIV Med. 2011;12 Suppl 2:112-39.
    PubMed     Text format     Related articles   
    
    
    
    
44. NELSON M , Dockrell D, Edwards S, Angus B, et al
    British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011.
    HIV Med. 2011;12 Suppl 2:1-140.
    PubMed     Text format     Related articles   
    
    
    
    August 2011
45. COZZI-LEPRI A , Paredes R, Phillips A, Clotet B, et al
    The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI(*).
    HIV Med. 2011 Aug 17. doi: 10.1111/j.1468-1293.2011.00943.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. KEANE F , Gompels M, Bendall R, Drayton R, et al
    Hepatitis E virus coinfection in patients with HIV infection.
    HIV Med. 2011 Aug 7. doi: 10.1111/j.1468-1293.2011.00942.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. VROUENRAETS S , Wit F, Fernandez Garcia E, Moyle G, et al
    Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naive HIV-1-infected patients.
    HIV Med. 2011 Aug 7. doi: 10.1111/j.1468-1293.2011.00941.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. MURRAY M , Hogg R, Lima V, May M, et al
    The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis.
    HIV Med. 2011 Aug 7. doi: 10.1111/j.1468-1293.2011.00940.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. KADHEL P , Multigner L, Bardinet F, Goerger-Sow M, et al
    Cervical intraepithelial neoplasia and invasive cancer risks in women infected with HIV in the French West Indies.
    HIV Med. 2011 Aug 7. doi: 10.1111/j.1468-1293.2011.00939.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. MCMANUS H , Li P, Nolan D, Bloch M, et al
    Does use of antiretroviral therapy regimens with high central nervous system penetration improve survival in HIV-infected adults?
    HIV Med. 2011 Aug 7. doi: 10.1111/j.1468-1293.2011.00938.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. LARSEN M , Harboe Z, Ladelund S, Skov R, et al
    Major but differential decline in the incidence of Staphylococcus aureus bacteraemia in HIV-infected individuals from 1995 to 2007: a nationwide cohort study(*).
    HIV Med. 2011 Aug 7. doi: 10.1111/j.1468-1293.2011.00937.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. WATERS L , Fisher M, Anderson J, Wood C, et al
    Authors' response to Drs Scourfield, Jackson and Nelson.
    HIV Med. 2011;12:450-451.
    PubMed     Text format     Related articles   
    
    
    
    
53. SCOURFIELD A , Jackson A, Nelson M
    Will earlier diagnosis of HIV infection in late presenters reduce the frequency of serious opportunistic infections?
    HIV Med. 2011;12:449-50.
    PubMed     Text format     Related articles   
    
    
    
    
54. ZINNA S , Bamford A, Cunnington A, Kampmann B, et al
    Immunization status of children with HIV: failure to protect a vulnerable population.
    HIV Med. 2011;12:447-8.
    PubMed     Text format     Related articles   
    
    
    
    
55. SAUMOY M , Tiraboschi J, Gutierrez M, Niubo J, et al
    Viral response in stable patients switching to fosamprenavir/ritonavir monotherapy (the FONT Study).
    HIV Med. 2011;12:438-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. JACOBSON M , Lurain N, Hunt P
    Cytomegalovirus viraemia in the modern antiretroviral era(*).
    HIV Med. 2011;12:387-8.
    PubMed     Text format     Related articles   
    
    
    
    July 2011
57. L'HUILLIER A , Ferry T, Courvoisier D, Aebi C, et al
    Impaired antibody memory to varicella zoster virus in HIV-infected children: low antibody levels and avidity(*).
    HIV Med. 2011 Jul 3. doi: 10.1111/j.1468-1293.2011.00936.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. 
    Paediatric European Network for Treatment of AIDS response to 2010 revision of World Health Organization recommendations on 'Antiretroviral therapy for HIV infection in infants and children'.
    HIV Med. 2011;12:385-6.
    PubMed     Text format     Related articles   
    
    
    
    
59. SUZAN-MONTI M , Fugon L, Marcellin F, Carrieri M, et al
    Reduced delays in time to first HIV consultation after diagnosis in France in the antiretroviral therapy era: the possible role of a free care system.
    HIV Med. 2011;12:383-384.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
60. VLACHOPOULOS C , Xaplanteris P, Sambatakou H, Mariolis E, et al
    Acute systemic inflammation induced by influenza A (H1N1) vaccination causes a deterioration in endothelial function in HIV-infected patients.
    HIV Med. 2011 Jun 5. doi: 10.1111/j.1468-1293.2011.00935.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
61. FEENEY E , Chazallon C, O'Brien N, Meiffredy V, et al
    Hyperlactataemia in HIV-infected subjects initiating antiretroviral therapy in a large randomized study (a substudy of the INITIO trial).
    HIV Med. 2011 May 22. doi: 10.1111/j.1468-1293.2011.00934.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. ROCKSTROH J , Teppler H, Zhao J, Sklar P, et al
    Safety and efficacy of raltegravir in patients with HIV-1 and hepatitis B and/or C virus coinfection.
    HIV Med. 2011 May 22. doi: 10.1111/j.1468-1293.2011.00933.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. SAVVIDOU M , Samuel M, Akolekar R, Poulton M, et al
    First trimester maternal uterine artery Doppler examination in HIV-positive women.
    HIV Med. 2011 May 16. doi: 10.1111/j.1468-1293.2011.00930.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. HUGHES R , Sterne J, Walsh J, Bansi L, et al
    Long-term trends in CD4 cell counts and impact of viral failure in individuals starting antiretroviral therapy: UK Collaborative HIV Cohort (CHIC) study.
    HIV Med. 2011 May 16. doi: 10.1111/j.1468-1293.2011.00929.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. CONRADIE F , Zorrilla C, Josipovic D, Botes M, et al
    Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women.
    HIV Med. 2011 May 16. doi: 10.1111/j.1468-1293.2011.00927.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. GRIERSON J , Koelmeyer R, Smith A, Pitts M, et al
    Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians.
    HIV Med. 2011 May 9. doi: 10.1111/j.1468-1293.2011.00928.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
67. IWUJI C , Mayanja B, Weiss H, Atuhumuza E, et al
    Morbidity in HIV-1-infected individuals before and after the introduction of antiretroviral therapy: a longitudinal study of a population-based cohort in Uganda.
    HIV Med. 2011 Apr 27. doi: 10.1111/j.1468-1293.2011.00923.
    PubMed     Text format     Related articles   
    
    
    
    
68. VERHOFSTEDE C , Brudney D, Reynaerts J, Vaira D, et al
    Concordance between HIV-1 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA.
    HIV Med. 2011 Apr 25. doi: 10.1111/j.1468-1293.2011.00922.
    PubMed     Text format     Related articles   
    
    
    
    
69. KENYA S , Chida N, Symes S, Shor-Posner G, et al
    Can community health workers improve adherence to highly active antiretroviral therapy in the USA? A review of the literature.
    HIV Med. 2011 Apr 24. doi: 10.1111/j.1468-1293.2011.00921.
    PubMed     Text format     Related articles   
    
    
    
    
70. PODZAMCZER D , Andrade-Villanueva J, Clotet B, Taylor S, et al
    Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naive HIV-1-infected patients (the ARTEN study).
    HIV Med. 2011 Apr 24. doi: 10.1111/j.1468-1293.2011.00917.
    PubMed     Text format     Related articles   
    
    
    
    
71. IZURIETA P , Kakuda T, Feys C, Witek J, et al
    Safety and pharmacokinetics of etravirine in pregnant HIV-1-infected women(*).
    HIV Med. 2011;12:257-8.
    PubMed     Text format     Related articles   
    
    
    
    
72. BUCKTON A , Prabhu D, Motamed C, Harris R, et al
    Increased detection of the HIV-1 reverse transcriptase M184V mutation using mutation-specific minority assays in a UK surveillance study suggests evidence of unrecognized transmitted drug resistance(*).
    HIV Med. 2011;12:250-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. TURNER D
    Does the M184V resistance mutation in reverse transcriptase reduce HIV transmission?(*).
    HIV Med. 2011;12:193-4.
    PubMed     Text format     Related articles   
    
    
    
    
74. 
    Abstracts of the 17th Annual Conference of the British HIV Association (BHIVA). April 6-8, 2011. Bournemouth, United Kingdom.
    HIV Med. 2011;12 Suppl 1:1-91.
    PubMed     Text format     Related articles   
    
    
    
    
75. LIN AW , Yam WC, Lam HY, To S, et al
    Pharmacogenetic screening: HLA-B(*) 5701 vs. CYP2B6 G516T.
    HIV Med. 2011;12:255-6.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
76. YEHIA B , Fleishman J, Wilson L, Hicks P, et al
    Incidence of and risk factors for bacteraemia in HIV-infected adults in the era of highly active antiretroviral therapy.
    HIV Med. 2011 Mar 23. doi: 10.1111/j.1468-1293.2011.00919.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. TAYLOR G , Anderson J, Clayden P, Gazzard B, et al
    British HIV Association and Children's HIV Association position statement on infant feeding in the UK 2011.
    HIV Med. 2011 Mar 21. doi: 10.1111/j.1468-1293.2011.00918.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. TRIMOULET P , Belzunce C, Faure M, Wittkop L, et al
    Hepatitis C virus (HCV) protease variability and anti-HCV protease inhibitor resistance in HIV/HCV-coinfected patients.
    HIV Med. 2011 Mar 16. doi: 10.1111/j.1468-1293.2011.00913.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. CARCELERO E , Tuset M, Martin M, De Lazzari E, et al
    Evaluation of antiretroviral-related errors and interventions by the clinical pharmacist in hospitalized HIV-infected patients.
    HIV Med. 2011 Mar 13. doi: 10.1111/j.1468-1293.2011.00915.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. KOSKI L , Brouillette MJ, Lalonde R, Hello B, et al
    Computerized testing augments pencil-and-paper tasks in measuring HIV-associated mild cognitive impairment(*).
    HIV Med. 2011 Mar 13. doi: 10.1111/j.1468-1293.2010.00910.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. BRIZ V , Palladino C, Navarro M, Jimenez de Ory S, et al
    Etravirine-based highly active antiretroviral therapy in HIV-1-infected paediatric patients.
    HIV Med. 2011 Mar 13. doi: 10.1111/j.1468-1293.2010.00907.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. EDWARDS-JACKSON N , Kerr S, Tieu H, Ananworanich J, et al
    Cardiovascular risk assessment in persons with HIV infection in the developing world: comparing three risk equations in a cohort of HIV-infected Thais.
    HIV Med. 2011 Mar 6. doi: 10.1111/j.1468-1293.2011.00916.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. NEUKAM K , Nattermann J, Rallon N, Rivero A, et al
    Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype.
    HIV Med. 2011 Mar 6. doi: 10.1111/j.1468-1293.2011.00912.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. GONZALEZ G , Park S, Chen D, Armitage S, et al
    Identification and frequency of CCR5Delta32/Delta32 HIV-resistant cord blood units from Houston area hospitals.
    HIV Med. 2011 Mar 6. doi: 10.1111/j.1468-1293.2010.00911.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
85. PEREZ-HOYOS S , Naniche D, Macete E, Aponte J, et al
    Stabilization of HIV incidence in women of reproductive age in southern Mozambique.
    HIV Med. 2011 Feb 23. doi: 10.1111/j.1468-1293.2010.00908.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. DE SOCIO G , Ricci E, Bonfanti P, Quirino T, et al
    Waist circumference and body mass index in HIV infection.
    HIV Med. 2011;12:124-5.
    PubMed     Text format     Related articles   
    
    
    
    January 2011
87. SIVAKUMAR T , Mechanic O, Fehmie D, Paul B, et al
    Growth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled trials.
    HIV Med. 2011 Jan 25. doi: 10.1111/j.1468-1293.2010.00906.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. MARTINEZ E , Marcos M, Hoyo-Ulloa I, Anton A, et al
    Influenza A H1N1 in HIV-infected adults(*).
    HIV Med. 2011 Jan 24. doi: 10.1111/j.1468-1293.2010.00905.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. CRUM-CIANFLONE N , Krause D, Wessman D, Medina S, et al
    Fatty liver disease is associated with underlying cardiovascular disease in HIV-infected persons(*).
    HIV Med. 2011 Jan 20. doi: 10.1111/j.1468-1293.2010.00904.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. HAILE-SELASSIE H , Townsend C, Tookey P
    Use of neonatal post-exposure prophylaxis for prevention of mother-to-child HIV transmission in the UK and Ireland, 2001-2008.
    HIV Med. 2011 Jan 20. doi: 10.1111/j.1468-1293.2010.00902.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. PETOUMENOS K , Worm S, Reiss P, de Wit S, et al
    Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*).
    HIV Med. 2011 Jan 20. doi: 10.1111/j.1468-1293.2010.00901.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. BARDE C , Piguet V, Pechere M, Masouye I, et al
    Management of resistant mucocutaneous herpes simplex infections in AIDS patients: a clinical and virological challenge.
    HIV Med. 2011 Jan 20. doi: 10.1111/j.1468-1293.2010.00896.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. ESCOTE X , Megia A, Lopez-Dupla M, Miranda M, et al
    A study of fatty acid binding protein 4 in HIV-1 infection and in combination antiretroviral therapy-related metabolic disturbances and lipodystrophy.
    HIV Med. 2011 Jan 19. doi: 10.1111/j.1468-1293.2010.00903.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. EL AMARI EB , Combescure C, Yerly S, Calmy A, et al
    Clinical relevance of cytomegalovirus viraemia(*).
    HIV Med. 2011 Jan 19. doi: 10.1111/j.1468-1293.2010.00900.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. DIONG C , Raboud J, Li M, Cooper C, et al
    HIV/hepatitis C virus and HIV/hepatitis B virus coinfections protect against antiretroviral-related hyperlipidaemia.
    HIV Med. 2011 Jan 18. doi: 10.1111/j.1468-1293.2010.00897.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from Boehringer Ingelheim.

Amedeo is a Flying Publisher website.    Design: